Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion

October 1, 2018 updated by: Amr Hatem Ahmed Mohammed, Assiut University
A study that compares between Open TLIF and Minimally invasive TLIF regarding patients' functional status(Oswestry Disability index)as a primary outcome measure.

Study Overview

Detailed Description

The first randomized controlled trial comparing minimally invasive TLIF and open TLIF.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults more than 18 years of age and less than 65 years of age..
  • Degenerative or isthmic spondylolithesis Grade 1,2 and 3.
  • Recurrent Symptomatic recurrent lumbar disc prolapsed with or without evident neural compression.
  • Single level pathology involving L2-3, L3-4, L4-5 and or L5-S1.
  • Symptoms not responding to conservative treatment for at least 3 months.

Exclusion Criteria:

  • Previous spinal fusion or instrumentation.
  • Spinal tumours, infection and fractures.
  • Patients with severe osteoporosis
  • BMI more than 35.
  • Non-ambulant patients and patients with severe preoperative neurological affection (Cauda Equina Syndrome)
  • Patients not willing to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: O-TLIF group
Spinal fusion ,Transforaminal lumbar interbody fusion procedure will be performed through open surgery.
Spinal fusion procedure through the intervertebral foramen
Other: MI-TLIF group
Spinal fusion,Transforaminal lumbar interbody fusion procedure will be performed through minimally invasive surgery using a tubular retractor.
Spinal fusion procedure through the intervertebral foramen

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oswestry Disability index(Arabic version) 1 month
Time Frame: 1 month
an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain.
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
• Fusion rate as assessed by Bridwell fusion score.
Time Frame: 1 year
Grade I is defined as fusion with remodelling and trabeculae present; Grade II is an intact graft with incomplete remodelling and no lucency present; Grade III is an intact graft with potential lucency at the cranial or caudal end; Grade IV is absent fusion with collapse/resorption of the graft.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

November 1, 2018

Primary Completion (Anticipated)

November 1, 2020

Study Completion (Anticipated)

October 1, 2021

Study Registration Dates

First Submitted

September 28, 2018

First Submitted That Met QC Criteria

October 1, 2018

First Posted (Actual)

October 2, 2018

Study Record Updates

Last Update Posted (Actual)

October 2, 2018

Last Update Submitted That Met QC Criteria

October 1, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 6272829

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Fusion

Clinical Trials on Transforaminal Lumbar Interbody Fusion either open or minimally invasive

Subscribe